FDAnews
FDAnews Drug Daily Bulletin

SYMBOLLON PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2006 RESULTS

May 25, 2006

Symbollon Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2006. The Company reported a net loss of $(548,771), or $(0.07) per share, compared with a net loss of $(183,547), or $(0.03) per share, in the prior year. The increased loss for such period resulted primarily from increased clinical development expenses related to IoGen™, salaries and related costs and facility expenses previously allocated to manufacturing, and consulting and other service expenses.
MacReport